Post-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damagethrough reduction of oxidative injury and nitric oxide enhancement in the ratmodel of myocardial infarction

Peptides

Volumn 46, Issue , 2013, Pages 76-82

  Azizi, Yaser ^a   Faghihi, Mahdieh ^a   Imani, Alireza ^a   Roghani, Mehrdad ^b   Nazari, Afshin ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

^c LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apelin; Cardioprotection; Lipid peroxidation; Myocardial infarction; Nitric oxide; Rat

Indexed keywords

(PYR1) APELIN 13; APELIN; CREATINE KINASE MB; LACTATE DEHYDROGENASE; MALONALDEHYDE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

APELIN; CARDIOPROTECTION; LIPID PEROXIDATION; MYOCARDIAL INFARCTION; NITRIC OXIDE; RAT;

ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CORONARY VESSELS; CREATINE KINASE, MB FORM; DISEASE MODELS, ANIMAL; HEART RATE; HEMODYNAMICS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 84879246051     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.05.006     Document Type: Article

References (54)

1. Ashley EA, Powers J, Chen M, Kundu R, Finsterbach T, Caffarelli A, et al. Theendogenous peptide apelin potently improves cardiac contractility and reducescardiac loading in vivo. Cardiovasc Res 2005;65:73-82.
2. Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM. Glucagon-like peptide1 can directly protect the heart against ischemia/reperfusion injury. Diabetes2005;54:146-51.
3. Bullard AJ, Govewalla P, Yellon DM. Erythropoietin protects the myocardiumagainst reperfusion injury in vitro and in vivo. Basic Res Cardiol2005;100:397-403.
4. Chandrasekaran B, Dar O, McDonagh T. The role of apelin in cardiovascularfunction and heart failure. Eur J Heart Fail 2008;10:725-32.
5. Chang L, Ren Y, Liu X, Li WG, Yang J, Geng B, et al. Protective effects of ghrelin onischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol2004;43:165-70.
6. Chao J, Yin H, Yao YY, Shen B, Smith Jr RS, Chao L. Novel role of kallistatinin protection against myocardial ischemia-reperfusion injury by preventingapoptosis and inflammation. Hum Gene Ther 2006;17:1201-13.
7. Cheng X, Cheng XS, Pang CC. Venous dilator effect of apelin, an endogenouspeptide ligand for the orphan APJ receptor, in conscious rats. Eur J Pharmacol2003;470:171-5.
8. Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R, et al. Apelin signalingantagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest2008;118:3343-54.
9. Dai T, Ramirez-Correa G, Gao WD. Apelin increases contractility in failing car-diac muscle. Eur J Pharmacol 2006;553:222-8.
10. Foussal C, Lairez O, Calise D, Pathak A, Guilbeau-Frugier C, Valet P, et al. Activa-tion of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy.FEBS Lett 2010;584:2363-70.
11. Gao L, Yin H, Smith SRJ, Chao L, Chao J. Role of kallistatin in prevention of cardiacremodeling after chronic myocardial infarction. Lab Invest 2008;88:1157-66.
12. Hori M, Nishida K. Oxidative stress and left ventricular remodelling aftermyocardial infarction. Cardiovasc Res 2009;81:457-64.
13. Huang CX, Yuan MJ, Huang H, Wu G, Liu Y, Yu SB, et al. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 2009;30:2286-91.
14. Huusko J, Merentie M, Dijkstra MH, Ryhanen MM, Karvinen H, Rissanen TT,et al. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses andleft ventricular function in mice. Cardiovasc Res 2010;86:122-30.
15. Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, Das DK. Pharmacologicalpreconditioning with resveratrol: an insight with iNOS knockout mice. Am JPhysiol Heart Circ Physiol 2002;282:H1996-2003.
16. Japp AG, Cruden NL, Amer DA, Li VK, Goudie EB, Johnston NR, et al. Vasculareffects of apelin in vivo in man. J Am Coll Cardiol 2008;52:908-13.
17. Japp AG, Cruden NL, Barnes G, van Gemeren N, Mathews J, Adamson J, et al.Acute cardiovascular effects of apelin in humans: potential role in patientswith chronic heart failure. Circulation 2010;121:1818-27.
18. Jeremias I, Kupatt C, Martin-Villalba A, Habazettl H, Schenkel J, Boekstegers P,et al. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia.Circulation 2000;102:915-20.
19. Jia YX, Pan CS, Zhang J, Geng B, Zhao J, Gerns H, et al. Apelin protects myocardialinjury induced by isoproterenol in rats. Regul Pept 2006;133:147-54.
20. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulinat reperfusion requires early administration and is mediated via Akt and p70s6kinase cell-survival signaling. Circ Res 2001;89:1191-8.
21. Kawachi K, Iso Y, Sato T, Wakabayashi K, Kobayashi Y, Takeyama Y, et al. Effectsof erythropoietin on angiogenesis after myocardial infarction in porcine. HeartVessels 2012;27:79-88.
22. Khalili M, Kiasalari Z, Roghani M, Azizi Y. Anticonvulsant and antioxidant effectof hydro-alcoholic extract of Cyperus rotundus rhizome on pentylentetrazole-induced kindling model in male mice. J Med Plants Res 2011;5:1140-6.
23. Kleinz MJ, Skepper JN, Davenport AP. Immunocytochemical localisation of theapelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle andendothelial cells. Regul Pept 2005;126:233-40.
24. Koguchi W, Kobayashi N, Takeshima H, Ishikawa M, Sugiyama F, Ishimitsu T.Cardioprotective effect of apelin-13 on cardiac performance and remodeling inend-stage heart failure. Circ J 2012;76:137-44.
25. Kunduzova O, Alet N, Delesque-Touchard N, Millet L, Castan-Laurell I, Muller C,et al. Apelin/APJ signaling system: a potential link between adipose tissue andendothelial angiogenic processes. FASEB J 2008;22:4146-53.
26. Maguire JJ, Kleinz MJ, Pitkin SL, Davenport AP. [Pyr(1)]Apelin-13 identified asthe predominant apelin isoform in the human heart vasoactive mechanismsand inotropic action in disease. Hypertension 2009;54:598-604.
27. Mitsos S, Katsanos K, Koletsis E, Kagadis GC, Anastasiou N, Diamantopoulos A,et al. Therapeutic angiogenesis for myocardial ischemia revisited: basic biolog-ical concepts and focus on latest clinical trials. Angiogenesis 2012;15:1-22.
28. Nazari A, Sadr A, Campillo-Funollet M, Nakashima S, Shimada Y, Tagami J, et al.Effect of hydration on assessment of early enamel lesion using swept-sourceoptical coherence tomography. J Biophotonics 2013;6:171-7.
29. Panda VS, Naik SR. Cardioprotective activity of Ginkgo biloba Phytosomes inisoproterenol-induced myocardial necrosis in rats: a biochemical and histoar-chitectural evaluation. Exp Toxicol Pathol 2008;60:397-404.
30. Penna C, Pasqua T, Perrelli MG, Pagliaro P, Cerra MC, Angelone T. Postcondi-tioning with glucagon like peptide-2 reduces ischemia/reperfusion injury inisolated rat hearts: role of survival kinases and mitochondrial KATP channels.Basic Res Cardiol 2012;107:272.
31. Pisarenko OI, Pelogeykina YA, Bespalova Zh D, Serebryakova LI, Sidorova MV,Az'muko AA, et al. Limitation of myocardial infarction by a structural analog ofthe peptide apelin-12. Dokl Biol Sci 2012;443:65-7.
32. Rakhit RD, Mojet MH, Marber MS, Duchen MR. Mitochondria as targets fornitric oxide-induced protection during simulated ischemia and reoxygenationin isolated neonatal cardiomyocytes. Circulation 2001;103:2617-23.
33. Rastaldo R, Cappello S, Folino A, Berta GN, Sprio AE, Losano G, et al. Apelin-13limits infarct size and improves cardiac postischemic mechanical recovery onlyif given after ischemia. Am J Physiol Heart Circ Physiol 2011;300. H2308-H15.
34. Rastaldo R, Pagliaro P, Cappello S, Penna C, Mancardi D, Westerhof N, et al.Nitric oxide and cardiac function. Life Sci 2007;81:779-93.
35. Robich MP, Matyal R, Chu LM, Feng J, Xu SH, Laham RJ, et al. Effects of neu-ropeptide Y on collateral development in a swine model of chronic myocardialischemia. J Mol Cell Cardiol 2010;49:1022-30.
36. Ronkainen VP, Ronkainen JJ, Hanninen SL, Leskinen H, Ruas JL, Pereira T, et al.Hypoxia inducible factor regulates the cardiac expression and secretion ofapelin. FASEB J 2007;21:1821-30.
37. Schuh J, Fairclough Jr GF, Haschemeyer RH. Oxygen-mediated hetero-geneity of apo-low-density lipoprotein. Proc Natl Acad Sci USA 1978;75:3173-7.
38. Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, Ardigo D, et al. In vivogenetic profiling and cellular localization of apelin reveals a hypoxia-sensitive,endothelial-centered pathway activated in ischemic heart failure. Am J PhysiolHeart Circ Physiol 2008;294:H88-98.
39. Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M, et al.Overexpression of glutathione peroxidase prevents left ventricular remod-eling and failure after myocardial infarction in mice. Circulation 2004;109:544-9.
40. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC. Apelin-13and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Res Cardiol 2007;102:518-28.
41. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, et al. Postconditioningthe human heart. Circulation 2005;112:2143-8.
42. Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H, et al. Apelin,the novel endogenous ligand of the orphan receptor APJ, regulates cardiaccontractility. Circ Res 2002;91:434-40.
43. Tanguy S, Rakotovao A, Jouan MG, Ghezzi C, de Leiris J, Boucher F. Dietaryselenium intake influences Cx43 dephosphorylation, TNF-alpha expressionand cardiac remodeling after reperfused infarction. Mol Nutr Food Res2011;55:522-9.
44. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, et al. Isolationand characterization of a novel endogenous peptide ligand for the human APJreceptor. Biochem Biophys Res Commun 1998;251:471-6.
45. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K, et al. Thenovel peptide apelin lowers blood pressure via a nitric oxide-dependent mech-anism. Regul Pept 2001;99:87-92.
46. Verma S, Fedak PW, Weisel RD, Butany J, Rao V, Maitland A, et al. Fundamentalsof reperfusion injury for the clinical cardiologist. Circulation 2002;105:2332-6.
47. Wang L, Chen Q, Li G, Ke D. Ghrelin stimulates angiogenesis via GHSR1a-dependent MEK/ERK and PI3K/Akt signal pathways in rat cardiac microvascularendothelial cells. Peptides 2012;33:92-100.
48. Xiao J, Lv Y, Lin S, Jin L, Zhang Y, Wang X, et al. Cardiac protection by basicfibroblast growth factor from ischemia/reperfusion-induced injury in diabeticrats. Biol Pharm Bull 2010;33:444-9.
49. Xu X, Zhao W, Lao S, Wilson BS, Erikson JM, Zhang JQ. Effects of exercise andL-arginine on ventricular remodeling and oxidative stress. Med Sci Sports Exerc2010;42:346-54.
50. Yao F, Modgil A, Zhang Q, Pingili A, Singh N, O'Rourke ST, et al. Pressor effect ofapelin-13 in the rostral ventrolateral medulla: role of NAD(P)H oxidase-derivedsuperoxide. J Pharmacol Exp Ther 2011;336:372-80.
51. Zeng XJ, Zhang LK, Wang HX, Lu LQ, Ma LQ, Tang CS. Apelin protects heartagainst ischemia/reperfusion injury in rat. Peptides 2009;30:1144-52.
52. Zhao T, Xi L, Chelliah J, Levasseur JE, Kukreja RC. Inducible nitric oxidesynthase mediates delayed myocardial protection induced by activation ofadenosine A(1) receptors: evidence from gene-knockout mice. Circulation2000;102:902-7.
53. Zhong JC, Yu XY, Huang Y, Yung LM, Lau CW, Lin SG. Apelin modulates aorticvascular tone via endothelial nitric oxide synthase phosphorylation pathwayin diabetic mice. Cardiovasc Res 2007;74:388-95.
54. Zhou SX, Zhou Y, Zhang YL, Lei J, Wang JF. Antioxidant probucol attenu-ates myocardial oxidative stress and collagen expressions in post-myocardialinfarction rats. J Cardiovasc Pharmacol 2009;54:154-62.